Global Naftopidil Tablets Market Growth 2026-2032

September 2026 | 88 pages | ID: GC74F82EB2E7EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Naftopidil Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.

Naftopidil is an ?-receptor antagonist, which can relieve the sympathetic tension of the prostate and urethra by blocking adrenaline ?1 receptors, reduce urethral pressure, and improve urination disorders caused by benign prostatic hyperplasia, etc. symptom.

United States market for Naftopidil Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

China market for Naftopidil Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Europe market for Naftopidil Tablets is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.

Global key Naftopidil Tablets players cover Asahi Kasei Corporation, Beijing SL Pharmaceutical Co.,Ltd., Hubei Qianjiang Pharmaceutical Co., Ltd., Shanghai Shyndec Pharmaceutical Co., Ltd., Hainan Simcere Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.

LP Information, Inc. (LPI) ' newest research report, the “Naftopidil Tablets Industry Forecast” looks at past sales and reviews total world Naftopidil Tablets sales in 2025, providing a comprehensive analysis by region and market sector of projected Naftopidil Tablets sales for 2026 through 2032. With Naftopidil Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Naftopidil Tablets industry.

This Insight Report provides a comprehensive analysis of the global Naftopidil Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Naftopidil Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Naftopidil Tablets market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Naftopidil Tablets and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Naftopidil Tablets.

This report presents a comprehensive overview, market shares, and growth opportunities of Naftopidil Tablets market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
  • 25mg/tablet
  • 50mg/tablet
Segmentation by Application:
  • Hospital
  • Retail Pharmacy
  • Clinic
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Asahi Kasei Corporation
  • Beijing SL Pharmaceutical Co.,Ltd.
  • Hubei Qianjiang Pharmaceutical Co., Ltd.
  • Shanghai Shyndec Pharmaceutical Co., Ltd.
  • Hainan Simcere Pharmaceutical Co., Ltd.
  • Bengbu Fengyuan Pharmaceutical Co., Ltd.
  • GUIZHOU-EAKAN Pharmaceutical Co., Ltd.
  • Tonghua Jitong Medical Co., Ltd.
  • Nanjing Meirui Pharma Co., Ltd.
  • Shenzhen Neptunus Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
  • What is the 10-year outlook for the global Naftopidil Tablets market?
  • What factors are driving Naftopidil Tablets market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Naftopidil Tablets market opportunities vary by end market size?
  • How does Naftopidil Tablets break out by Type, by Application?
1 SCOPE OF THE REPORT

  1.1 Market Introduction
  1.2 Years Considered
  1.3 Research Objectives
  1.4 Market Research Methodology
  1.5 Research Process and Data Source
  1.6 Economic Indicators
  1.7 Currency Considered
  1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

  2.1 World Market Overview
  2.1.1 Global Naftopidil Tablets Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Naftopidil Tablets by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Naftopidil Tablets by Country/Region, 2021, 2025 & 2032
  2.2 Naftopidil Tablets Segment by Type
  2.2.1 25mg/tablet
  2.2.2 50mg/tablet
  2.2.3 Naftopidil Tablets Sales by Type
  2.2.3.1 Global Naftopidil Tablets Sales Market Share by Type (2021-2026)
  2.2.3.2 Global Naftopidil Tablets Revenue and Market Share by Type (2021-2026)
  2.2.3.3 Global Naftopidil Tablets Sale Price by Type (2021-2026)
  2.3 Naftopidil Tablets Segment by Application
  2.3.1 Hospital
  2.3.2 Retail Pharmacy
  2.3.3 Clinic
  2.3.4 Others
  2.3.5 Naftopidil Tablets Sales by Application
  2.3.5.1 Global Naftopidil Tablets Sale Market Share by Application (2021-2026)
  2.3.5.2 Global Naftopidil Tablets Revenue and Market Share by Application (2021-2026)
  2.3.5.3 Global Naftopidil Tablets Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

  3.1 Global Naftopidil Tablets Breakdown Data by Company
  3.1.1 Global Naftopidil Tablets Annual Sales by Company (2021-2026)
  3.1.2 Global Naftopidil Tablets Sales Market Share by Company (2021-2026)
  3.2 Global Naftopidil Tablets Annual Revenue by Company (2021-2026)
  3.2.1 Global Naftopidil Tablets Revenue by Company (2021-2026)
  3.2.2 Global Naftopidil Tablets Revenue Market Share by Company (2021-2026)
  3.3 Global Naftopidil Tablets Sale Price by Company
  3.4 Key Manufacturers Naftopidil Tablets Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Naftopidil Tablets Product Location Distribution
  3.4.2 Players Naftopidil Tablets Products Offered
  3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
  3.6 New Products and Potential Entrants
  3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR NAFTOPIDIL TABLETS BY GEOGRAPHIC REGION

  4.1 World Historic Naftopidil Tablets Market Size by Geographic Region (2021-2026)
  4.1.1 Global Naftopidil Tablets Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Naftopidil Tablets Annual Revenue by Geographic Region (2021-2026)
  4.2 World Historic Naftopidil Tablets Market Size by Country/Region (2021-2026)
  4.2.1 Global Naftopidil Tablets Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Naftopidil Tablets Annual Revenue by Country/Region (2021-2026)
  4.3 Americas Naftopidil Tablets Sales Growth
  4.4 APAC Naftopidil Tablets Sales Growth
  4.5 Europe Naftopidil Tablets Sales Growth
  4.6 Middle East & Africa Naftopidil Tablets Sales Growth

5 AMERICAS

  5.1 Americas Naftopidil Tablets Sales by Country
  5.1.1 Americas Naftopidil Tablets Sales by Country (2021-2026)
  5.1.2 Americas Naftopidil Tablets Revenue by Country (2021-2026)
  5.2 Americas Naftopidil Tablets Sales by Type (2021-2026)
  5.3 Americas Naftopidil Tablets Sales by Application (2021-2026)
  5.4 United States
  5.5 Canada
  5.6 Mexico
  5.7 Brazil

6 APAC

  6.1 APAC Naftopidil Tablets Sales by Region
  6.1.1 APAC Naftopidil Tablets Sales by Region (2021-2026)
  6.1.2 APAC Naftopidil Tablets Revenue by Region (2021-2026)
  6.2 APAC Naftopidil Tablets Sales by Type (2021-2026)
  6.3 APAC Naftopidil Tablets Sales by Application (2021-2026)
  6.4 China
  6.5 Japan
  6.6 South Korea
  6.7 Southeast Asia
  6.8 India
  6.9 Australia
  6.10 China Taiwan

7 EUROPE

  7.1 Europe Naftopidil Tablets by Country
  7.1.1 Europe Naftopidil Tablets Sales by Country (2021-2026)
  7.1.2 Europe Naftopidil Tablets Revenue by Country (2021-2026)
  7.2 Europe Naftopidil Tablets Sales by Type (2021-2026)
  7.3 Europe Naftopidil Tablets Sales by Application (2021-2026)
  7.4 Germany
  7.5 France
  7.6 UK
  7.7 Italy
  7.8 Russia

8 MIDDLE EAST & AFRICA

  8.1 Middle East & Africa Naftopidil Tablets by Country
  8.1.1 Middle East & Africa Naftopidil Tablets Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Naftopidil Tablets Revenue by Country (2021-2026)
  8.2 Middle East & Africa Naftopidil Tablets Sales by Type (2021-2026)
  8.3 Middle East & Africa Naftopidil Tablets Sales by Application (2021-2026)
  8.4 Egypt
  8.5 South Africa
  8.6 Israel
  8.7 Turkey
  8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

  9.1 Market Drivers & Growth Opportunities
  9.2 Market Challenges & Risks
  9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

  10.1 Raw Material and Suppliers
  10.2 Manufacturing Cost Structure Analysis of Naftopidil Tablets
  10.3 Manufacturing Process Analysis of Naftopidil Tablets
  10.4 Industry Chain Structure of Naftopidil Tablets

11 MARKETING, DISTRIBUTORS AND CUSTOMER

  11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
  11.2 Naftopidil Tablets Distributors
  11.3 Naftopidil Tablets Customer

12 WORLD FORECAST REVIEW FOR NAFTOPIDIL TABLETS BY GEOGRAPHIC REGION

  12.1 Global Naftopidil Tablets Market Size Forecast by Region
  12.1.1 Global Naftopidil Tablets Forecast by Region (2027-2032)
  12.1.2 Global Naftopidil Tablets Annual Revenue Forecast by Region (2027-2032)
  12.2 Americas Forecast by Country (2027-2032)
  12.3 APAC Forecast by Region (2027-2032)
  12.4 Europe Forecast by Country (2027-2032)
  12.5 Middle East & Africa Forecast by Country (2027-2032)
  12.6 Global Naftopidil Tablets Forecast by Type (2027-2032)
  12.7 Global Naftopidil Tablets Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

  13.1 Asahi Kasei Corporation
  13.1.1 Asahi Kasei Corporation Company Information
  13.1.2 Asahi Kasei Corporation Naftopidil Tablets Product Portfolios and Specifications
  13.1.3 Asahi Kasei Corporation Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Asahi Kasei Corporation Main Business Overview
  13.1.5 Asahi Kasei Corporation Latest Developments
  13.2 Beijing SL Pharmaceutical Co.,Ltd.
  13.2.1 Beijing SL Pharmaceutical Co.,Ltd. Company Information
  13.2.2 Beijing SL Pharmaceutical Co.,Ltd. Naftopidil Tablets Product Portfolios and Specifications
  13.2.3 Beijing SL Pharmaceutical Co.,Ltd. Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 Beijing SL Pharmaceutical Co.,Ltd. Main Business Overview
  13.2.5 Beijing SL Pharmaceutical Co.,Ltd. Latest Developments
  13.3 Hubei Qianjiang Pharmaceutical Co., Ltd.
  13.3.1 Hubei Qianjiang Pharmaceutical Co., Ltd. Company Information
  13.3.2 Hubei Qianjiang Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
  13.3.3 Hubei Qianjiang Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Hubei Qianjiang Pharmaceutical Co., Ltd. Main Business Overview
  13.3.5 Hubei Qianjiang Pharmaceutical Co., Ltd. Latest Developments
  13.4 Shanghai Shyndec Pharmaceutical Co., Ltd.
  13.4.1 Shanghai Shyndec Pharmaceutical Co., Ltd. Company Information
  13.4.2 Shanghai Shyndec Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
  13.4.3 Shanghai Shyndec Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Shanghai Shyndec Pharmaceutical Co., Ltd. Main Business Overview
  13.4.5 Shanghai Shyndec Pharmaceutical Co., Ltd. Latest Developments
  13.5 Hainan Simcere Pharmaceutical Co., Ltd.
  13.5.1 Hainan Simcere Pharmaceutical Co., Ltd. Company Information
  13.5.2 Hainan Simcere Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
  13.5.3 Hainan Simcere Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Hainan Simcere Pharmaceutical Co., Ltd. Main Business Overview
  13.5.5 Hainan Simcere Pharmaceutical Co., Ltd. Latest Developments
  13.6 Bengbu Fengyuan Pharmaceutical Co., Ltd.
  13.6.1 Bengbu Fengyuan Pharmaceutical Co., Ltd. Company Information
  13.6.2 Bengbu Fengyuan Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
  13.6.3 Bengbu Fengyuan Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Bengbu Fengyuan Pharmaceutical Co., Ltd. Main Business Overview
  13.6.5 Bengbu Fengyuan Pharmaceutical Co., Ltd. Latest Developments
  13.7 GUIZHOU-EAKAN Pharmaceutical Co., Ltd.
  13.7.1 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Company Information
  13.7.2 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
  13.7.3 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Main Business Overview
  13.7.5 GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Latest Developments
  13.8 Tonghua Jitong Medical Co., Ltd.
  13.8.1 Tonghua Jitong Medical Co., Ltd. Company Information
  13.8.2 Tonghua Jitong Medical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
  13.8.3 Tonghua Jitong Medical Co., Ltd. Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Tonghua Jitong Medical Co., Ltd. Main Business Overview
  13.8.5 Tonghua Jitong Medical Co., Ltd. Latest Developments
  13.9 Nanjing Meirui Pharma Co., Ltd.
  13.9.1 Nanjing Meirui Pharma Co., Ltd. Company Information
  13.9.2 Nanjing Meirui Pharma Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
  13.9.3 Nanjing Meirui Pharma Co., Ltd. Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 Nanjing Meirui Pharma Co., Ltd. Main Business Overview
  13.9.5 Nanjing Meirui Pharma Co., Ltd. Latest Developments
  13.10 Shenzhen Neptunus Pharmaceutical Co., Ltd.
  13.10.1 Shenzhen Neptunus Pharmaceutical Co., Ltd. Company Information
  13.10.2 Shenzhen Neptunus Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
  13.10.3 Shenzhen Neptunus Pharmaceutical Co., Ltd. Naftopidil Tablets Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Shenzhen Neptunus Pharmaceutical Co., Ltd. Main Business Overview
  13.10.5 Shenzhen Neptunus Pharmaceutical Co., Ltd. Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Naftopidil Tablets Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Naftopidil Tablets Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 25mg/tablet
Table 4. Major Players of 50mg/tablet
Table 5. Global Naftopidil Tablets Sales by Type (2021-2026) & (K Units)
Table 6. Global Naftopidil Tablets Sales Market Share by Type (2021-2026)
Table 7. Global Naftopidil Tablets Revenue by Type (2021-2026) & ($ million)
Table 8. Global Naftopidil Tablets Revenue Market Share by Type (2021-2026)
Table 9. Global Naftopidil Tablets Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Naftopidil Tablets Sale by Application (2021-2026) & (K Units)
Table 11. Global Naftopidil Tablets Sale Market Share by Application (2021-2026)
Table 12. Global Naftopidil Tablets Revenue by Application (2021-2026) & ($ million)
Table 13. Global Naftopidil Tablets Revenue Market Share by Application (2021-2026)
Table 14. Global Naftopidil Tablets Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Naftopidil Tablets Sales by Company (2021-2026) & (K Units)
Table 16. Global Naftopidil Tablets Sales Market Share by Company (2021-2026)
Table 17. Global Naftopidil Tablets Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Naftopidil Tablets Revenue Market Share by Company (2021-2026)
Table 19. Global Naftopidil Tablets Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Naftopidil Tablets Producing Area Distribution and Sales Area
Table 21. Players Naftopidil Tablets Products Offered
Table 22. Naftopidil Tablets Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Naftopidil Tablets Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Naftopidil Tablets Sales Market Share Geographic Region (2021-2026)
Table 27. Global Naftopidil Tablets Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Naftopidil Tablets Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Naftopidil Tablets Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Naftopidil Tablets Sales Market Share by Country/Region (2021-2026)
Table 31. Global Naftopidil Tablets Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Naftopidil Tablets Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Naftopidil Tablets Sales by Country (2021-2026) & (K Units)
Table 34. Americas Naftopidil Tablets Sales Market Share by Country (2021-2026)
Table 35. Americas Naftopidil Tablets Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Naftopidil Tablets Sales by Type (2021-2026) & (K Units)
Table 37. Americas Naftopidil Tablets Sales by Application (2021-2026) & (K Units)
Table 38. APAC Naftopidil Tablets Sales by Region (2021-2026) & (K Units)
Table 39. APAC Naftopidil Tablets Sales Market Share by Region (2021-2026)
Table 40. APAC Naftopidil Tablets Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Naftopidil Tablets Sales by Type (2021-2026) & (K Units)
Table 42. APAC Naftopidil Tablets Sales by Application (2021-2026) & (K Units)
Table 43. Europe Naftopidil Tablets Sales by Country (2021-2026) & (K Units)
Table 44. Europe Naftopidil Tablets Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Naftopidil Tablets Sales by Type (2021-2026) & (K Units)
Table 46. Europe Naftopidil Tablets Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Naftopidil Tablets Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Naftopidil Tablets Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Naftopidil Tablets Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Naftopidil Tablets Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Naftopidil Tablets
Table 52. Key Market Challenges & Risks of Naftopidil Tablets
Table 53. Key Industry Trends of Naftopidil Tablets
Table 54. Naftopidil Tablets Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Naftopidil Tablets Distributors List
Table 57. Naftopidil Tablets Customer List
Table 58. Global Naftopidil Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Naftopidil Tablets Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Naftopidil Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Naftopidil Tablets Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Naftopidil Tablets Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Naftopidil Tablets Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Naftopidil Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Naftopidil Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Naftopidil Tablets Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Naftopidil Tablets Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Naftopidil Tablets Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Naftopidil Tablets Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Naftopidil Tablets Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Naftopidil Tablets Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Asahi Kasei Corporation Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 73. Asahi Kasei Corporation Naftopidil Tablets Product Portfolios and Specifications
Table 74. Asahi Kasei Corporation Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Asahi Kasei Corporation Main Business
Table 76. Asahi Kasei Corporation Latest Developments
Table 77. Beijing SL Pharmaceutical Co.,Ltd. Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 78. Beijing SL Pharmaceutical Co.,Ltd. Naftopidil Tablets Product Portfolios and Specifications
Table 79. Beijing SL Pharmaceutical Co.,Ltd. Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Beijing SL Pharmaceutical Co.,Ltd. Main Business
Table 81. Beijing SL Pharmaceutical Co.,Ltd. Latest Developments
Table 82. Hubei Qianjiang Pharmaceutical Co., Ltd. Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 83. Hubei Qianjiang Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
Table 84. Hubei Qianjiang Pharmaceutical Co., Ltd. Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Hubei Qianjiang Pharmaceutical Co., Ltd. Main Business
Table 86. Hubei Qianjiang Pharmaceutical Co., Ltd. Latest Developments
Table 87. Shanghai Shyndec Pharmaceutical Co., Ltd. Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 88. Shanghai Shyndec Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
Table 89. Shanghai Shyndec Pharmaceutical Co., Ltd. Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Shanghai Shyndec Pharmaceutical Co., Ltd. Main Business
Table 91. Shanghai Shyndec Pharmaceutical Co., Ltd. Latest Developments
Table 92. Hainan Simcere Pharmaceutical Co., Ltd. Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 93. Hainan Simcere Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
Table 94. Hainan Simcere Pharmaceutical Co., Ltd. Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Hainan Simcere Pharmaceutical Co., Ltd. Main Business
Table 96. Hainan Simcere Pharmaceutical Co., Ltd. Latest Developments
Table 97. Bengbu Fengyuan Pharmaceutical Co., Ltd. Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 98. Bengbu Fengyuan Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
Table 99. Bengbu Fengyuan Pharmaceutical Co., Ltd. Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Bengbu Fengyuan Pharmaceutical Co., Ltd. Main Business
Table 101. Bengbu Fengyuan Pharmaceutical Co., Ltd. Latest Developments
Table 102. GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 103. GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
Table 104. GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Main Business
Table 106. GUIZHOU-EAKAN Pharmaceutical Co., Ltd. Latest Developments
Table 107. Tonghua Jitong Medical Co., Ltd. Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 108. Tonghua Jitong Medical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
Table 109. Tonghua Jitong Medical Co., Ltd. Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Tonghua Jitong Medical Co., Ltd. Main Business
Table 111. Tonghua Jitong Medical Co., Ltd. Latest Developments
Table 112. Nanjing Meirui Pharma Co., Ltd. Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 113. Nanjing Meirui Pharma Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
Table 114. Nanjing Meirui Pharma Co., Ltd. Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Nanjing Meirui Pharma Co., Ltd. Main Business
Table 116. Nanjing Meirui Pharma Co., Ltd. Latest Developments
Table 117. Shenzhen Neptunus Pharmaceutical Co., Ltd. Basic Information, Naftopidil Tablets Manufacturing Base, Sales Area and Its Competitors
Table 118. Shenzhen Neptunus Pharmaceutical Co., Ltd. Naftopidil Tablets Product Portfolios and Specifications
Table 119. Shenzhen Neptunus Pharmaceutical Co., Ltd. Naftopidil Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Shenzhen Neptunus Pharmaceutical Co., Ltd. Main Business
Table 121. Shenzhen Neptunus Pharmaceutical Co., Ltd. Latest Developments

LIST OF FIGURES

Figure 1. Picture of Naftopidil Tablets
Figure 2. Naftopidil Tablets Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Naftopidil Tablets Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Naftopidil Tablets Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Naftopidil Tablets Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Naftopidil Tablets Sales Market Share by Country/Region (2025)
Figure 10. Naftopidil Tablets Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 25mg/tablet
Figure 12. Product Picture of 50mg/tablet
Figure 13. Global Naftopidil Tablets Sales Market Share by Type in 2026
Figure 14. Global Naftopidil Tablets Revenue Market Share by Type (2021-2026)
Figure 15. Naftopidil Tablets Consumed in Hospital
Figure 16. Global Naftopidil Tablets Market: Hospital (2021-2026) & (K Units)
Figure 17. Naftopidil Tablets Consumed in Retail Pharmacy
Figure 18. Global Naftopidil Tablets Market: Retail Pharmacy (2021-2026) & (K Units)
Figure 19. Naftopidil Tablets Consumed in Clinic
Figure 20. Global Naftopidil Tablets Market: Clinic (2021-2026) & (K Units)
Figure 21. Naftopidil Tablets Consumed in Others
Figure 22. Global Naftopidil Tablets Market: Others (2021-2026) & (K Units)
Figure 23. Global Naftopidil Tablets Sale Market Share by Application (2025)
Figure 24. Global Naftopidil Tablets Revenue Market Share by Application in 2026
Figure 25. Naftopidil Tablets Sales by Company in 2026 (K Units)
Figure 26. Global Naftopidil Tablets Sales Market Share by Company in 2026
Figure 27. Naftopidil Tablets Revenue by Company in 2026 ($ millions)
Figure 28. Global Naftopidil Tablets Revenue Market Share by Company in 2026
Figure 29. Global Naftopidil Tablets Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Naftopidil Tablets Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Naftopidil Tablets Sales 2021-2026 (K Units)
Figure 32. Americas Naftopidil Tablets Revenue 2021-2026 ($ millions)
Figure 33. APAC Naftopidil Tablets Sales 2021-2026 (K Units)
Figure 34. APAC Naftopidil Tablets Revenue 2021-2026 ($ millions)
Figure 35. Europe Naftopidil Tablets Sales 2021-2026 (K Units)
Figure 36. Europe Naftopidil Tablets Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Naftopidil Tablets Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Naftopidil Tablets Revenue 2021-2026 ($ millions)
Figure 39. Americas Naftopidil Tablets Sales Market Share by Country in 2026
Figure 40. Americas Naftopidil Tablets Revenue Market Share by Country (2021-2026)
Figure 41. Americas Naftopidil Tablets Sales Market Share by Type (2021-2026)
Figure 42. Americas Naftopidil Tablets Sales Market Share by Application (2021-2026)
Figure 43. United States Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Naftopidil Tablets Sales Market Share by Region in 2026
Figure 48. APAC Naftopidil Tablets Revenue Market Share by Region (2021-2026)
Figure 49. APAC Naftopidil Tablets Sales Market Share by Type (2021-2026)
Figure 50. APAC Naftopidil Tablets Sales Market Share by Application (2021-2026)
Figure 51. China Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 55. India Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Naftopidil Tablets Sales Market Share by Country in 2026
Figure 59. Europe Naftopidil Tablets Revenue Market Share by Country (2021-2026)
Figure 60. Europe Naftopidil Tablets Sales Market Share by Type (2021-2026)
Figure 61. Europe Naftopidil Tablets Sales Market Share by Application (2021-2026)
Figure 62. Germany Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 63. France Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Naftopidil Tablets Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Naftopidil Tablets Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Naftopidil Tablets Sales Market Share by Application (2021-2026)
Figure 70. Egypt Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Naftopidil Tablets Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Naftopidil Tablets in 2026
Figure 76. Manufacturing Process Analysis of Naftopidil Tablets
Figure 77. Industry Chain Structure of Naftopidil Tablets
Figure 78. Channels of Distribution
Figure 79. Global Naftopidil Tablets Sales Market Forecast by Region (2027-2032)
Figure 80. Global Naftopidil Tablets Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Naftopidil Tablets Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Naftopidil Tablets Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Naftopidil Tablets Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Naftopidil Tablets Revenue Market Share Forecast by Application (2027-2032)


More Publications